Terns Pharmaceuticals, Inc. Comprehensive Income
Terns Pharmaceuticals, Inc. reported Comprehensive Income of -$95.67 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-03-30
- Terns Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$23.42M.
- Terns Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$24.50M.
- Terns Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-06-30 was -$24.17M.
- Terns Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-03-31 was -$23.58M.
- Terns Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$95.67M.
- Terns Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$89.11M.
- Terns Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$89.41M.
- Terns Pharmaceuticals, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$60.83M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$23.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$47.92M derived: sum of 2 quarters · filed 2026-03-30 | -$72.09M derived: sum of 3 quarters · filed 2026-03-30 | -$95.67M 10-K · filed 2026-03-30 |
| 2025-09-30 | -$24.50M 10-Q · filed 2025-11-10 | -$48.67M derived: sum of 2 quarters · filed 2025-11-10 | -$72.25M 10-Q · filed 2025-11-10 | -$94.49M derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-06-30 | -$24.17M 10-Q · filed 2025-08-05 | -$47.74M 10-Q · filed 2025-08-05 | -$69.98M derived: sum of 3 quarters · filed 2026-03-30 | -$91.32M derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-03-31 | -$23.58M 10-Q · filed 2025-05-08 | -$45.82M derived: sum of 2 quarters · filed 2026-03-30 | -$67.16M derived: sum of 3 quarters · filed 2026-03-30 | -$90.02M derived: sum of 4 quarters · filed 2026-03-30 |
| 2024-12-31 | -$22.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$43.58M derived: sum of 2 quarters · filed 2026-03-30 | -$66.44M derived: sum of 3 quarters · filed 2026-03-30 | -$89.11M 10-K · filed 2026-03-30 |
| 2024-09-30 | -$21.34M 10-Q · filed 2025-11-10 | -$44.20M derived: sum of 2 quarters · filed 2025-11-10 | -$66.88M 10-Q · filed 2025-11-10 | -$87.08M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$22.86M 10-Q · filed 2025-08-05 | -$45.53M 10-Q · filed 2025-08-05 | -$65.73M derived: sum of 3 quarters · filed 2025-08-05 | -$95.56M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | -$22.68M 10-Q · filed 2025-05-08 | -$42.88M derived: sum of 2 quarters · filed 2025-05-08 | -$72.70M derived: sum of 3 quarters · filed 2025-05-08 | -$90.96M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$20.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$50.03M derived: sum of 2 quarters · filed 2025-03-20 | -$68.28M derived: sum of 3 quarters · filed 2025-03-20 | -$89.41M 10-K · filed 2025-03-20 |
| 2023-09-30 | -$29.83M 10-Q · filed 2024-11-12 | -$48.08M derived: sum of 2 quarters · filed 2024-11-12 | -$69.20M 10-Q · filed 2024-11-12 | -$84.50M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$18.25M 10-Q · filed 2024-08-05 | -$39.38M 10-Q · filed 2024-08-05 | -$54.67M derived: sum of 3 quarters · filed 2024-08-05 | -$71.60M derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | -$21.12M 10-Q · filed 2024-05-13 | -$36.42M derived: sum of 2 quarters · filed 2024-05-13 | -$53.34M derived: sum of 3 quarters · filed 2024-05-13 | -$67.62M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$15.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$32.22M derived: sum of 2 quarters · filed 2024-03-14 | -$46.50M derived: sum of 3 quarters · filed 2024-03-14 | -$60.83M 10-K · filed 2024-03-14 |
| 2022-09-30 | -$16.93M 10-Q · filed 2023-11-14 | -$31.20M derived: sum of 2 quarters · filed 2023-11-14 | -$45.53M 10-Q · filed 2023-11-14 | -$59.95M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$14.28M 10-Q · filed 2023-08-08 | -$28.61M 10-Q · filed 2023-08-08 | -$43.02M derived: sum of 3 quarters · filed 2023-08-08 | -$54.85M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$14.33M 10-Q · filed 2023-05-15 | -$28.75M derived: sum of 2 quarters · filed 2023-05-15 | -$40.58M derived: sum of 3 quarters · filed 2023-05-15 | -$51.26M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$14.42M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$26.25M derived: sum of 2 quarters · filed 2023-03-27 | -$36.93M derived: sum of 3 quarters · filed 2023-03-27 | -$50.37M 10-K · filed 2023-03-27 |
| 2021-09-30 | -$11.83M 10-Q · filed 2022-11-09 | -$22.51M derived: sum of 2 quarters · filed 2022-11-09 | -$35.95M 10-Q · filed 2022-11-09 | -$46.10M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$10.68M 10-Q · filed 2022-08-08 | -$24.13M 10-Q · filed 2022-08-08 | -$34.27M derived: sum of 3 quarters · filed 2022-08-08 | -$45.50M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$13.45M 10-Q · filed 2022-05-16 | -$23.59M derived: sum of 2 quarters · filed 2022-05-16 | -$34.82M derived: sum of 3 quarters · filed 2022-05-16 | -$44.65M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$10.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | -$21.38M derived: sum of 2 quarters · filed 2022-03-07 | -$31.21M derived: sum of 3 quarters · filed 2022-03-07 | -$40.59M 10-K · filed 2022-03-07 |
| 2020-09-30 | -$11.23M 10-Q · filed 2021-11-15 | -$21.06M derived: sum of 2 quarters · filed 2021-11-15 | -$30.45M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$9.83M 10-Q · filed 2021-08-16 | -$19.21M 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | -$9.38M 10-Q · filed 2021-05-14 |